Brief: Immunoprecise Reports Financial Results And Recent Business Highlights For Full Fiscal Year 2023
July 7 (Reuters) - Immunoprecise Antibodies Ltd IPA.O :
* IMMUNOPRECISE REPORTS FINANCIAL RESULTS AND RECENT
BUSINESS
HIGHLIGHTS FOR FULL FISCAL YEAR 2023
* IMMUNOPRECISE ANTIBODIES LTD - RECORDED TOTAL REVENUE OF
$5.6
MILLION DURING THREE MONTHS ENDED APRIL 30, 2023
Source text for Eikon: ID:nBw8GbvjPa
Further company coverage: IPA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai